Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rebecca Jean Kahn, Ph.D.

Profile Picture

Duke UniversityBA05/2013Public Policy & Global Health
Harvard UniversityMS05/2018Epidemiology
Harvard UniversityPhD11/2020Population Health Sciences & Epidemiology

Rebecca Kahn is a Postdoctoral Research Fellow in the Center for Communicable Disease Dynamics at the Harvard T.H. Chan School of Public Health. After graduating with a BA in Public Policy and Global Health from Duke University, she worked with PEPFAR in the U.S. State Department Office of the Global AIDS Coordinator. She then worked for Partners In Health in Sierra Leone on the Ebola response and health systems strengthening programs. She earned her MS in Epidemiology in 2018 and her PhD in Population Health Sciences and Epidemiology in 2020 from Harvard. Her research focuses on using infectious disease modeling to enhance epidemic preparedness and response.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Kennedy-Shaffer L, Kahn R, Lipsitch M. Estimating Vaccine Efficacy Against Transmission via Effect on Viral Load. Epidemiology. 2021 11 01; 32(6):820-828. PMID: 34469363.
    Citations:    Fields:    Translation:HumansPHPublic Health
  2. Hambridge HL, Kahn R, Onnela JP. Examining SARS-CoV-2 Interventions in Residential Colleges Using an Empirical Network. Int J Infect Dis. 2021 Oct 05. PMID: 34624516.
    Citations: 1     Fields:    
  3. Kahn R, Wang R, Leavitt SV, Hanage WP, Lipsitch M. Leveraging Pathogen Sequence and Contact Tracing Data to Enhance Vaccine Trials in Emerging Epidemics. Epidemiology. 2021 09 01; 32(5):698-704. PMID: 34039898.
    Citations:    Fields:    Translation:HumansPHPublic Health
  4. Lau YC, Tsang TK, Kennedy-Shaffer L, Kahn R, Lau EHY, Chen D, Wong JY, Ali ST, Wu P, Cowling BJ. Joint Estimation Of Generation Time And Incubation Period For Coronavirus Disease (Covid-19). J Infect Dis. 2021 Aug 23. PMID: 34423821.
    Citations:    Fields:    
  5. Regev-Yochay G, Amit S, Bergwerk M, Lipsitch M, Leshem E, Kahn R, Lustig Y, Cohen C, Doolman R, Ziv A, Novikov I, Rubin C, Gimpelevich I, Huppert A, Rahav G, Afek A, Kreiss Y. Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel. Lancet Reg Health Eur. 2021 Aug; 7:100150. PMID: 34250518.
    Citations: 5     
  6. Lipsitch M, Kahn R. Interpreting vaccine efficacy trial results for infection and transmission. Vaccine. 2021 07 05; 39(30):4082-4088. PMID: 34130883.
    Citations: 3     Fields:    Translation:Humans
  7. Kahn R, Holmdahl I, Reddy S, Jernigan J, Mina MJ, Slayton RB. Mathematical modeling to inform vaccination strategies and testing approaches for COVID-19 in nursing homes. Clin Infect Dis. 2021 Jun 04. PMID: 34086877.
    Citations: 2     Fields:    
  8. Lipsitch M, Kahn R. Interpreting vaccine efficacy trial results for infection and transmission. medRxiv. 2021 May 27. PMID: 33655276.
  9. Holmdahl I, Kahn R, Hay JA, Buckee CO, Mina MJ. Estimation of Transmission of COVID-19 in Simulated Nursing Homes With Frequent Testing and Immunity-Based Staffing. JAMA Netw Open. 2021 05 03; 4(5):e2110071. PMID: 33988707.
    Citations: 1     Fields:    Translation:Humans
  10. Hambridge HL, Kahn R, Onnela JP. Examining SARS-CoV-2 Interventions in Residential Colleges Using an Empirical Network. medRxiv. 2021 Apr 10. PMID: 33758870.
  11. Kishore N, Kahn R, Martinez PP, De Salazar PM, Mahmud AS, Buckee CO. Lockdowns result in changes in human mobility which may impact the epidemiologic dynamics of SARS-CoV-2. Sci Rep. 2021 03 26; 11(1):6995. PMID: 33772076.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  12. Kahn R, Holmdahl I, Reddy S, Jernigan J, Mina MJ, Slayton RB. Mathematical modeling to inform vaccination strategies and testing approaches for COVID-19 in nursing homes. medRxiv. 2021 Mar 01. PMID: 33688668.
  13. Accorsi EK, Qiu X, Rumpler E, Kennedy-Shaffer L, Kahn R, Joshi K, Goldstein E, Stensrud MJ, Niehus R, Cevik M, Lipsitch M. How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19. Eur J Epidemiol. 2021 Feb; 36(2):179-196. PMID: 33634345.
    Citations: 11     Fields:    Translation:Humans
  14. Kahn R, Kennedy-Shaffer L, Grad YH, Robins JM, Lipsitch M. Potential Biases Arising From Epidemic Dynamics in Observational Seroprotection Studies. Am J Epidemiol. 2021 02 01; 190(2):328-335. PMID: 32870977.
    Citations: 3     Fields:    Translation:Humans
  15. Chang MC, Kahn R, Li YA, Lee CS, Buckee CO, Chang HH. Variation in human mobility and its impact on the risk of future COVID-19 outbreaks in Taiwan. BMC Public Health. 2021 01 27; 21(1):226. PMID: 33504339.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  16. Greene SK, McGough SF, Culp GM, Graf LE, Lipsitch M, Menzies NA, Kahn R. Nowcasting for Real-Time COVID-19 Tracking in New York City: An Evaluation Using Reportable Disease Data From Early in the Pandemic. JMIR Public Health Surveill. 2021 01 15; 7(1):e25538. PMID: 33406053.
    Citations: 1     Translation:HumansPHPublic Health
  17. Gostic KM, McGough L, Baskerville EB, Abbott S, Joshi K, Tedijanto C, Kahn R, Niehus R, Hay JA, De Salazar PM, Hellewell J, Meakin S, Munday JD, Bosse NI, Sherrat K, Thompson RN, White LF, Huisman JS, Scire J, Bonhoeffer S, Stadler T, Wallinga J, Funk S, Lipsitch M, Cobey S. Practical considerations for measuring the effective reproductive number, Rt. PLoS Comput Biol. 2020 12; 16(12):e1008409. PMID: 33301457.
    Citations: 43     Fields:    Translation:Humans
  18. Dean NE, Pastore Y Piontti A, Madewell ZJ, Cummings DAT, Hitchings MDT, Joshi K, Kahn R, Vespignani A, Halloran ME, Longini IM. Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials. Vaccine. 2020 10 27; 38(46):7213-7216. PMID: 33012602.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  19. Chin T, Kahn R, Li R, Chen JT, Krieger N, Buckee CO, Balsari S, Kiang MV. US-county level variation in intersecting individual, household and community characteristics relevant to COVID-19 and planning an equitable response: a cross-sectional analysis. BMJ Open. 2020 Sep 01; 10(9):e039886. PMID: 32873684.
    Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
  20. Chang MC, Kahn R, Li YA, Lee CS, Buckee CO, Chang HH. Variation in human mobility and its impact on the risk of future COVID-19 outbreaks in Taiwan. medRxiv. 2020 Aug 12. PMID: 32817972.
  21. Lipsitch M, Kahn R, Mina MJ. Antibody testing will enhance the power and accuracy of COVID-19-prevention trials. Nat Med. 2020 06; 26(6):818-819. PMID: 32341581.
    Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
  22. Peak CM, Kahn R, Grad YH, Childs LM, Li R, Lipsitch M, Buckee CO. Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study. Lancet Infect Dis. 2020 09; 20(9):1025-1033. PMID: 32445710.
    Citations: 64     Fields:    Translation:HumansCellsPHPublic Health
  23. Oxner A, Vellanki M, Myers A, Bangura F, Bangura S, Koroma AM, Massaqoui R, Gbao F, Kamanda D, Gassimu J, Kahn R. Reducing mortality from severe malaria in Sierra Leonean children by applying the World Health Organization's standard malarial protocol with additional sublingual glucose: A continuous quality improvement report. Int J Infect Dis. 2020 Jul; 96:61-67. PMID: 32339722.
    Citations:    Fields:    Translation:Humans
  24. Kahn R, Peak CM, Fern√°ndez-Gracia J, Hill A, Jambai A, Ganda L, Castro MC, Buckee CO. Incubation periods impact the spatial predictability of cholera and Ebola outbreaks in Sierra Leone. Proc Natl Acad Sci U S A. 2020 03 03; 117(9):5067-5073. PMID: 32054785.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  25. Kahn R, Mahmud AS, Schroeder A, Aguilar Ramirez LH, Crowley J, Chan J, Buckee CO. Rapid Forecasting of Cholera Risk in Mozambique: Translational Challenges and Opportunities. Prehosp Disaster Med. 2019 Oct; 34(5):557-562. PMID: 31477186.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  26. Garde DL, Kahn RJ, Mesman AW, Koroma AP, Marsh RH. Care of Pregnant Women: Experience from a Maternity-Specific Ebola Isolation Unit in Sierra Leone. J Midwifery Womens Health. 2019 Jul; 64(4):493-499. PMID: 31241247.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  27. Kahn R, Bangura S, Hann K, Salvi A, Gassimu J, Kabba A, Mesman AW, Dierberg KL, Marsh RH. Strengthening provision of essential medicines to women and children in post-Ebola Sierra Leone. J Glob Health. 2019 06; 9(1):010307. PMID: 31217949.
    Citations: 1     Fields:    Translation:Humans
  28. Kahn R, Hitchings M, Wang R, Bellan SE, Lipsitch M. Analyzing Vaccine Trials in Epidemics With Mild and Asymptomatic Infection. Am J Epidemiol. 2019 02 01; 188(2):467-474. PMID: 30329134.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  29. Kahn R, Rid A, Smith PG, Eyal N, Lipsitch M. Choices in vaccine trial design in epidemics of emerging infections. PLoS Med. 2018 08; 15(8):e1002632. PMID: 30086139.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  30. Kahn R, Hitchings M, Bellan S, Lipsitch M. Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trials. Clin Trials. 2018 04; 15(2):207-211. PMID: 29374974.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  31. Stabinski L, O'Connor S, Barnhart M, Kahn RJ, Hamm TE. Prevalence of HIV and hepatitis B virus co-infection in sub-Saharan Africa and the potential impact and program feasibility of hepatitis B surface antigen screening in resource-limited settings. . 2015 Apr 15; 68 Suppl 3:S274-85. PMID: 25768867.
    Citations: 23     Translation:HumansCellsPHPublic Health
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Kahn's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (109)
Co-Authors (18)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.